Biomatics Capital raises $300M fund, hires Gates Foundation global health director Mike Poole to lead neurology investments
Biomatics Capital raised a $300 million second fund to invest in 15–20 healthcare and life-sciences startups focused on innovations at the intersection of healthcare and technology, and added two partners — Dr. Mike Poole from the Bill & Melinda Gates Foundation to lead neurology-focused, data- and genomics-enabled investments, and biotech investor Errik Anderson.